Approval · Notice of Compliance 30832 · 2023
SPINRAZA: Notice of Compliance 30832
Issued May 24, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30832
- Date
- May 24, 2023
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph regarding missed dose. Conversion of the Product Monograph to the 2020 format. Updates to the package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPINRAZA | Not yet assigned | — |
Medicinal ingredients
- NUSINERSEN SODIUM 2.4 MG per ML